23 November 2017
News and Views
Links and Services
The latest Journal of Pediatrics assesses the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
Dr Susan Orenstein and colleagues assessed the efficacy and safety of lansoprazo
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors